February 2012

Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March

Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March

Minyanville

Merck settles lawsuit over delayed study results

Merck settles lawsuit over delayed study results

Yahoo/AP

2 Eli Lilly FDA Plays With Great Potential And Limited Downside

2 Eli Lilly FDA Plays With Great Potential And Limited Downside

Seeking Alpha

HGSI Narrows 4Q Loss, Benlysta Grows

HGSI Narrows 4Q Loss, Benlysta Grows

Yahoo/Zacks

Why Eli Lilly's Earnings Are Outstanding

Why Eli Lilly's Earnings Are Outstanding

Motley Fool

Will FDA Delay Approving The Eliquis Bloodthinner?

Will FDA Delay Approving The Eliquis Bloodthinner?

Pharmalot

Threshold Pharmaceuticals: Understanding The Recent Data

Threshold Pharmaceuticals: Understanding The Recent Data

Seeking Alpha

ViroPharma Beats Up on Analysts Yet Again

ViroPharma Beats Up on Analysts Yet Again

Motley Fool

Why Illumina's Earnings Are Outstanding

Why Illumina's Earnings Are Outstanding

Motley Fool

Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug

Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug

Seeking Alpha